<DOC>
	<DOCNO>NCT00086281</DOCNO>
	<brief_summary>To study effect Xyrem ( 9 g ) , Xyrem ( 9 g ) plus modafinil 200 mg administer morning prior Xyrem , positive control ( zolpidem 10 mg ) , placebo frequency outcome event sleep-disordered breathing patient obstructive sleep apnea syndrome ( OSAS ) .</brief_summary>
	<brief_title>Trial Effects Oral Xyrem Zolpidem Sleep-Disordered Breathing Obstructive Sleep Apnea Patients</brief_title>
	<detailed_description>This study conduct randomize , crossover study effect Xyrem ( 9 g ) , Xyrem ( 9 g ) plus modafinil 200 mg administer morning prior Xyrem , positive control ( zolpidem 10 mg ) , placebo frequency outcome event sleep-disordered breathing patient obstructive sleep apnea syndrome ( OSAS ) .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Signed date informed consent prior begin protocol require procedure . Willing able complete entire trial per protocol include 6 night sleep lab . 18 year age old . Have history obstructive sleep apnea syndrome ( per American Academy Sleep Medicine [ AASM ] Task Force 1999 ) . ApneaHypopnea Index ( AHI ) : 10 40 inclusive , low O2 saturation â‰¥75 % ( see AASM Task Force 1999 criterion ) Females may include surgically sterile , two year postmenopausal , childbearing potential , use medically accept method birth control ( e.g. , barrier method spermicide , oral contraceptive , abstinence ) agree continue use method duration trial . In opinion investigator adequate support duration trial include transportation trial site . In addition , investigator 's assessment clinically indicate , patient willing operate car heavy machinery duration trial long investigator deem clinically indicate . Have take sodium oxybate ( GHB ) last 30 day . Have take investigational therapy within 30day period prior initial screen visit trial . Are routinely take stimulant medication , sedative hypnotic , tranquilizer , antihistamine ( except nonsedating antihistamine ) , benzodiazepine clonidine start study . Patients take anticonvulsant eligible participate even willing washout anticonvulsant trial . Regularly consume alcohol unwilling unable totally abstain alcohol use trial duration . Are experience major illness , include unstable cardiovascular , endocrine , neoplastic , gastrointestinal , hematologic , hepatic , immunologic , metabolic , neurological , pulmonary , and/or renal disease would place patient risk trial compromise objective outline protocol . Have psychiatric disorder , major affective psychotic disorder , problem , investigator 's opinion , would preclude patient 's participation completion trial compromise reliable representation subjective symptom . Have current recent ( within one year ) history substance use disorder include alcohol abuse define DSMIV . Have serum creatinine great 2.0 mg/dL , abnormal liver function test ( SGOT [ AST ] SGPT [ ALT ] twice upper limit normal ) , elevate serum bilirubin ( 1.5 time upper limit normal ) , pretrial ECG result demonstrate clinically significant arrhythmia , great first degree AV block history myocardial infarction within last six month . Have occupation require variable shift work routine night shift . Have clinically significant history seizure disorder either past present , history clinically significant head trauma ( i.e. , concussion result clinically significant loss consciousness ) past invasive intracranial surgery , take anticonvulsant medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Sleep-disordered breathing</keyword>
	<keyword>Obstructive sleep apnea syndrome</keyword>
</DOC>